Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Fragile X Syndrome

• Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
• An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome
• Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
• An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
• A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome
• Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities
• A Randomized Study of BPN14770 in Male Adolescents (Aged 12 to < 18 Years) With Fragile X Syndrome
• Metformin in Children With Fragile X Syndrome
• Single Blind Study of Ergoloid Mesylates, 5-HTP and the Combination in Adult Males With Fragile X Syndrome
• Clinical Study of Cannabidiol in Children and Adolescents With Fragile X Syndrome
• Investigation of Sulindac in Male Fragile X Syndrome Patients Aged 13-40
• Novel Clinical Target in Fragile X Syndrome
• Neuroimaging GABA Physiology in Fragile X Syndrome
• Metformin in Patients With Fragile X
• A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
• Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
• Metformin in Children and Adults With Fragile X Syndrome
• A Study of OV101 in Individuals With Fragile X Syndrome
• Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)
• A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
• A Trial of Metformin in Individuals With Fragile X Syndrome
• An Initial Study of AZD7325 in Adults With Fragile X Syndrome
• Single Dose Pharmacokinetic (PK) Study
• Neurophysiological and Acute Pharmacological Studies in FXS Patients
• Clinical Trial for Asses the Safety and Efficacy of Vitamin C and Vitamin E in Combination Versus Placebo for Treating Cognitive and Behavior Disorder in Children With Fragile X Syndrome
• AFQ056 for Language Learning in Children With FXS
• Glutaminergic Transmission in Autism : Molecular Imaging Exploration
• Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome
• Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome
• Citocoline for Treatment of FXTAS
• A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome
• Study of Acamprosate in Fragile x Syndrome
• A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
• A Study of RO4917523 in Pediatric Patients With Fragile X Syndrome
• Ganaxolone Treatment in Children With Fragile X Syndrome
• An Open Label Extension Study in Subjects With Fragile X Syndrome
• A Study of RO4917523 in Patients With Fragile X Syndrome
• Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)
• Trial of Sertraline to Treat Children With Fragile X Syndrome
• Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)
• Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
• Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome
• A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome
• Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome
• Acamprosate in Youth With Fragile X Syndrome
• Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
• Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome
• Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome
• Randomized Controlled Study of Donepezil in Fragile X Syndrome
• Trial of Minocycline to Treat Children With Fragile X Syndrome
• A Study With RO4917523 in Patients With Fragile X Syndrome
• An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome
• A Single-Dose Study in Normal Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of STX107
• Riluzole in Fragile X Syndrome
• Biomarker and DNA Collection in Subjects Participating in Protocol 22003
• A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions
• Add-on Pilot Trial of Minocycline to Treat Fragile X Syndrome
• Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001
• Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome
• The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
• Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients
• Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome
• A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome
• An Open-Label Trial of Donepezil in Fragile X Syndrome
• Effects of CX516 on Functioning in Fragile X Syndrome and Autism